CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- 4 Shares withheld for taxes Chief Medical Officer gave up 5,263 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 5,452 shares (to pay taxes)
- 4 Option exercise Director acquired 30,752 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- POSASR Other POSASR
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4/A Derivatives Options or other derivatives
- 8-K Event Material agreement · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes Chief Medical Officer gave up 13,891 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 12,630 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 11,917 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
Page 7 of 41 · 806 filings